Bethany Sensenig - 01 Oct 2025 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
01 Oct 2025
Net transactions value
$0
Form type
3
Filing time
02 Oct 2025, 18:27:28 UTC
Previous filing
18 Aug 2025
Next filing
20 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sensenig Bethany Director C/O KALVISTA PHARMACEUTICALS, INC., 200 CROSSING BOULEVARD, FRAMINGHAM /s/ Benjamin L. Palleiko, Attorney-in-Fact 02 Oct 2025 0001899935

No securities are beneficially owned.